Pediatric Nonlymphoblastic Non-Hodgkin Lymphoma: Baseline, Interim, and Posttreatment PET/CT versus Contrast-enhanced CT for Evaluation—A Prospective Study

Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now?

(2010) N. George Mikhaeel   LEUKEMIA & LYMPHOMA

The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphoma

(2010) Kieron Dunleavy et al.   LEUKEMIA & LYMPHOMA

Role of PET/CT in malignant pediatric lymphoma

(2009) Raef Riad et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Early and Late Therapy Response Assessment With [18F]Fluorodeoxyglucose Positron Emission Tomography in Pediatric Hodgkin's Lymphoma: Analysis of a Prospective Multicenter Trial

(2009) Christian Furth et al.   JOURNAL OF CLINICAL ONCOLOGY

The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin’s lymphoma

(2008) Deok-Hwan Yang et al.   ANNALS OF HEMATOLOGY

Role of FDG PET in the management of childhood lymphomas – case proven or is the jury still out?

(2008) Ananth Shankar et al.   EUROPEAN JOURNAL OF CANCER